Voluntary Exercise Attenuates Tumor Growth in a Preclinical Model of Castration-Resistant Prostate Cancer

Nicolas Berger1, Benjamin Kugler1, Dong Han

  • 1Department of Exercise and Health Sciences, Manning College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA.

Abstract

Insights

Voluntary wheel running reduced tumor growth in a mouse model of Castration-Resistant Prostate Cancer (CRPC). This exercise delayed tumor progression by downregulating DNA replication, Androgen Receptor (AR) signaling, and angiogenesis pathways.

Area of Science:

  • Oncology
  • Exercise Physiology
  • Molecular Biology

Background:

  • Prostate cancer progression, particularly Castration-Resistant Prostate Cancer (CRPC), remains a significant clinical challenge.
  • Understanding the molecular mechanisms underlying tumor growth is crucial for developing novel therapeutic strategies.
  • The role of physical activity in cancer management is an emerging area of research.

Purpose of the Study:

  • To investigate the impact of voluntary wheel running (VWR) on tumor growth in a CRPC mouse model.
  • To explore the potential molecular pathways, including DNA replication, Androgen Receptor (AR) signaling, and mitochondrial dynamics, affected by VWR.

Main Methods:

  • A CRPC xenograft mouse model was established using human CWR-22RV1 cells.
  • Mice were divided into voluntary wheel running (VWR) and sedentary (SED) groups.
  • Tumor volume was monitored, and tumor tissues were analyzed for gene and protein expression using RT-PCR, western blotting, and transcriptomics.

Main Results:

  • VWR significantly reduced tumor volume and attenuated tumor progression compared to the SED group.
  • Reduced tumor growth correlated with lower mRNA expression of DNA replication markers (MCM2, MCM6, MCM7) and AR signaling targets (ELOVL5, FKBP5).
  • VWR also altered mitochondrial dynamics markers and downregulated pathways involved in angiogenesis and extracellular matrix formation.

Conclusions:

  • Three weeks of VWR effectively delayed tumor formation and progression in this CRPC model.
  • The observed benefits are associated with reduced transcription of DNA replication, AR signaling, and mitochondrial dynamics.
  • Downregulation of angiogenesis pathways may contribute to the anti-tumor effects of VWR.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide (Glucotrol),...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...